2005-12-13
Anti-inflammatory agent Elafin has been successfully tested in a Phase I clinical trial.
2005-11-24
Clinical trial commenced
2005-11-22
Proteo Biotech AG appoints new President and CEO
2005-04-07
Elafin for clinical testing
2004-12-01
Proteo Inc. / Proteo Biotech AG Signs an Exclusive License- and Collaboration- Agreement with Artes Biotechnology GmbH
2004-08-16
Proteo, Inc. listed and quoted in the over the counter segment of the Frankfurt Stock Exchange
2004-07-26
Research-Collaboration-Agreement between the Charité Berlin and Proteo Biotech AG
2004-07-14
Proteo Biotech AG / Proteo Inc. Announces the Successful Completion of the Preclinical Trials of Its Tissue Protective Agent Elafin – Clinical Trials Are Being Scheduled
